Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06283173 · ClinicalTrials.gov registry record · NA
HRIPT for Collagen Dressing
A NA study, sponsored by Covalon Technologies.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT06283173 is a NA study that has completed, run by Covalon Technologies. The registered enrollment target is 86 participants.
The verdict
NCT06283173, a NA study, has completed, sponsored by Covalon Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
The objectives of this study are to determine by repetitive epidermal contact, the primary or cumulative irritation and the allergic contact sensitization potential of the ColActive Plus Collagen Matrix Dressing, under maximized conditions, with controlled product quantity and application site.
Interventions
- DEVICE ColActive Plus Collagen Matrix Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06283173
The ClinicalTrials.gov registry entry for NCT06283173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Covalon Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ColActive Plus Collagen Matrix Dressing is the first listed.
NCT06283173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06283173 about?
NCT06283173 is a clinical study titled "HRIPT for Collagen Dressing". The objectives of this study are to determine by repetitive epidermal contact, the primary or cumulative irritation and the allergic contact sensitization potential of the ColActive Plus Collagen Matrix Dressing, under maximized conditions, with controlled product quantity and application site.
What is the current status of trial NCT06283173?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2024-01-31. Estimated completion is 2024-03-22.
What interventions are being tested in trial NCT06283173?
The interventions under investigation include: ColActive Plus Collagen Matrix Dressing (DEVICE).
Who is sponsoring clinical trial NCT06283173?
This trial is sponsored by Covalon Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.